FSSNX
Price
$29.97
Change
+$0.22 (+0.74%)
Updated
Nov 8 closing price
TSVCX
Price
$12.68
Change
+$0.09 (+0.71%)
Updated
Nov 8 closing price
Ad is loading...

FSSNX vs TSVCX

Header iconFSSNX vs TSVCX Comparison
Open Charts FSSNX vs TSVCXBanner chart's image
Fidelity Small Cap Index
Price$29.97
Change+$0.22 (+0.74%)
VolumeN/A
CapitalizationN/A
Timothy Plan Small Cap Value C
Price$12.68
Change+$0.09 (+0.71%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FSSNX vs TSVCX Comparison Chart
Loading...
VS
FSSNX vs. TSVCX commentary
Nov 10, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSSNX is a StrongBuy and TSVCX is a Buy.

FUNDAMENTALS
Fundamentals
FSSNX has more cash in the bank: 26.9B vs. TSVCX (204M). FSSNX pays higher dividends than TSVCX: FSSNX (1.36) vs TSVCX (0.51). FSSNX was incepted earlier than TSVCX: FSSNX (13 years) vs TSVCX (21 years). TSVCX is a more actively managed with annual turnover of: 55.00 vs. FSSNX (9.00). FSSNX has a lower initial minimum investment than TSVCX: FSSNX (0) vs TSVCX (1000). FSSNX annual gain was more profitable for investors over the last year : 44.42 vs. TSVCX (23.32). FSSNX return over 5 years is better than : 53.40 vs. TSVCX (4.43).
FSSNXTSVCXFSSNX / TSVCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years21 years-
Gain YTD19.84912.113164%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets26.9B204M13,186%
Annual Yield % from dividends1.360.51267%
Returns for 1 year44.4223.32190%
Returns for 3 years0.98-18.42-5%
Returns for 5 years53.404.431,204%
Returns for 10 years94.72-27.71-342%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DNLI31.351.75
+5.91%
Denali Therapeutics
FLUT248.0410.06
+4.23%
Flutter Entertainment plc
ADCT2.93N/A
N/A
ADC Therapeutics SA
LGVN2.20N/A
N/A
Longeveron
AUPH8.32-0.02
-0.24%
Aurinia Pharmaceuticals